`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`MYLAN PHARMACEUTICALS INC.,
`Petitioner
`
`v .
`
`BOEHRINGER INGELHEIM INTERNATIONAL GMBH,
`Patent Owner.
`
`Case IPR2016-01565
`Patent 8,853,156 B2
`
`Mailed: August 17, 2016
`
`CERTIFICATION OF WORD COUNT OF PETITION
`PURSUANT TO 37 C.F.R. 42.24(d)
`
`
`
`Case IPR2016-01565
`Patent 8,853,156 B2
`
`Pursuant to 37 C.F.R. §42.24, Petitioner hereby certifies that the Petition
`
`filed August 10, 2016 contains 6,520 words, excluding the parts of the Petition
`
`exempted by 37 C.F.R. § 42.24(a)(1). Counsel for Petitioner obtained this word
`
`count using the “Word Count” function of Microsoft Word 2013.
`
`Date: August 17, 2016
`
`RESPECTFULLY SUBMITTED,
`ALSTON & BIRD LLP
`
`Thomas J. Parker (Reg. No. 42,062)
`thomas.parker@alston.com
`ALSTON & BIRD LLP
`90 Park Avenue, 15th Floor
`New York, NY 10016
`T: (212) 210-9529
`F: (212) 210-9444
`
`Lead Counsel for Petitioner
`
`
`
`CERTIFICATION OF SERVICE
`Pursuant to 37 C.F.R. §§ 42.6(e), the undersigned certifies that on the 17th
`
`day of August 2016, a complete copy of the foregoing Certification of Word Count
`
`of Petition Pursuant to 37 C.F.R. 42.24(d) was served via Priority Mail Express®
`
`to the Patent Owner by serving the correspondence address of record for the ’156
`
`patent:
`
`Michael P. Morris
`Boehringer Ingelheim USA Corporation
`900 Ridgebury Road
`P. O. Box 368
`Ridgefield, CT 06877-0368
`
`Respectfully submitted,
`
`ALSTON & BIRD LLP
`
`Thomas J. Parker (Reg. No. 42,062)
`thomas.parker@alston.com
`ALSTON & BIRD LLP
`90 Park Avenue, 15th Floor
`New York, NY 10016
`T: (212) 210-9529
`F: (212) 210-9444
`
`Counsel for Mylan Pharmaceuticals Inc.